Boston Scientific Corp. BSX
$52.01
+3.05%
at last close
Analyst Consensus
- Consensus Rating
- Buy (21 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $71.91
- Implied Upside
- +38.3%
- Price Target Range
- $50.00 – $118.00
- Analysts (12 mo)
- 24
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-31 | Argus ResearchDavid Toung |
Downgrades | Buy → Hold | — |
| 2026-07-30 | UBSPatrick Wood |
Maintains | Buy | $74 → $67 |
| 2026-07-30 | CitigroupJoanne Wuensch |
Maintains | Buy | $70 → $61 |
| 2026-07-30 | RBC CapitalKendall Au |
Maintains | Outperform | $85 → $70 |
| 2026-07-30 | TD CowenJoshua Jennings |
Maintains | Buy | $61 → $56 |
| 2026-07-30 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $70 → $66 |
| 2026-07-30 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $62 → $57 |
| 2026-07-30 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $65 → $55 |
| 2026-07-30 | Wells FargoLarry Biegelsen |
Maintains | Equal-weight | $55 → $50 |
| 2026-07-29 | BTIGMarie Thibault |
Maintains | Buy | $65 → $60 |
| 2026-07-28 | UBSPatrick Wood |
Assumes | Buy | $95 → $74 |
| 2026-07-27 | OppenheimerSuraj Kalia |
Maintains | Outperform | $90 → $85 |
| 2026-07-16 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $64 → $62 |
| 2026-07-15 | MizuhoAnthony Petrone |
Maintains | Outperform | $90 → $70 |
| 2026-07-13 | RBC CapitalShagun Singh |
Maintains | Outperform | $100 → $85 |
| 2026-07-08 | NeedhamMike Matson |
Maintains | Buy | $77 → $57 |
| 2026-07-06 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $78 → $65 |
| 2026-06-25 | StifelRick Wise |
Maintains | Buy | $75 → $65 |
| 2026-06-24 | JefferiesMatthew Taylor |
Maintains | Buy | $100 → $67 |
| 2026-06-16 | BTIGMarie Thibault |
Reiterates | Buy | $65 |
| 2026-06-04 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $85 → $64 |
| 2026-06-03 | BTIGMarie Thibault |
Maintains | Buy | $80 → $65 |
| 2026-06-01 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $71 → $70 |
| 2026-05-29 | Wolfe ResearchMike Polark |
Downgrades | Outperform → Peer perform | — |
| 2026-05-28 | CitigroupJoanne Wuensch |
Maintains | Buy | $87 → $70 |
| 2026-05-28 | Leerink PartnersMike Kratky |
Maintains | Outperform | $87 → $74 |
| 2026-05-28 | BarclaysMatt Miksic |
Maintains | Overweight | $96 → $89 |
| 2026-05-28 | Wells FargoLarry Biegelsen |
Downgrades | Overweight → Equal-weight | $75 → $55 |
| 2026-05-19 | BairdDavid Rescott |
Maintains | Outperform | $78 → $75 |
| 2026-05-18 | B of A SecuritiesBob Hopkins |
Maintains | Buy | $105 → $68 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $52.01
- Market Cap
- $73.14 billion
- 52-Week Range
- $42.20 – $109.50
- Average Volume
- 18.63 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.